Coherus Oncology, Inc. CHRS
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Return on equity has no reading this year — return on capital employed, just below, still does: -128%.
The 14-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.3 | 0.2 | 0.3 | 0.5 | 0.4 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.2 | −0.2 | −0.2 | −0.3 | −0.3 | 0.2 | 0.1 | −0.2 | −0.2 | −0.1 | −0.2 | −0.1 | −0.0 | −0.0 |
| EBITDA $B | −0.2 | −0.2 | −0.2 | −0.3 | −0.3 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | −0.1 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ◌ | ◌ |
| Net income $B | 0.2 | 0.0 | −0.2 | −0.3 | −0.3 | 0.1 | 0.1 | −0.2 | −0.2 | −0.1 | −0.2 | −0.1 | −0.1 | −0.0 |
| Free cash flow $B | ◌ | ◌ | −0.2 | −0.2 | −0.0 | 0.1 | 0.0 | −0.2 | −0.2 | −0.3 | −0.1 | −0.0 | 0.0 | −0.0 |
| EPS, diluted $ | 1.43 | 0.25 | −2.53 | −3.76 | −3.81 | 1.62 | 1.23 | −3.22 | −4.48 | −3.04 | −6.01 | −10.64 | −16.10 | −15.85 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | — | — | — | — | −151.6 | 68.5 | — | — | −932.9 | — | — | — | — | — |
| Shares out B | 0.12 | 0.12 | 0.11 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.04 | 0.03 | 0.00 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 12 of the 14 fiscal years we could check. 12 checks were skipped: the balance sheet is not tagged before 2013. 12 checks were skipped: cost of revenue is not tagged before 2019. Five checks were skipped: EPS is not tagged before 2012.